Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Aclarion, Inc. (ACON)
Company Research
Source: Yahoo! Finance
New Patent Allows Aclarion Exclusive Access to Enhanced Post-processing Techniques of Magnetic Resonance Spectroscopy (MRS) to Improve Data Quality Aclarion's Patent Portfolio Continues to Grow in Support of a Platform Technology That can be Leveraged for Potential Future MRS Product Expansions Into Breast, Prostate, and Brain BROOMFIELD, CO - ( NewMediaWire ) - June 20, 2024 - Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW) , a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for the 23rd US patent that will be issued to the Company. The patent relates to novel post-processing techniques to improve the quality of the spectral data derived from non-invasive MRS exams. This improved quality enables more accurate quantificati
Show less
Read more
Impact Snapshot
Event Time:
ACON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACON alerts
High impacting Aclarion, Inc. news events
Weekly update
A roundup of the hottest topics
ACON
News
- Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK [Yahoo! Finance]Yahoo! Finance
- Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKGlobeNewswire
- Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London [Yahoo! Finance]Yahoo! Finance
- Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonGlobeNewswire
- Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution [Yahoo! Finance]Yahoo! Finance
ACON
Sec Filings
- 6/26/24 - Form 8-K
- 6/25/24 - Form QUALIF
- 6/20/24 - Form 1-A/A
- ACON's page on the SEC website